Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net loss $ (4,122,033) $ (3,089,703)
Adjustments to reconcile net loss to net cash used in operating activities:    
Accrued interest/dividends 52,104
Accretion of Debt Discount 608,460
Loss on sale of securities 1,650
Loss on fair market value of equity investments 3,092
Share based compensation – restricted shares issued to vendors 15,998
Share based compensation – stock options issued to employees 81,002
Changes in assets and liabilities    
Decrease/(increase) in prepaid expenses 222,226 (4,097)
Increase in trade and other payables 1,431,487 927,935
Increase in right-of-use liabilities 396 119
Net cash used in operating activities (2,366,182) (1,505,182)
Cash flows from investing activities:    
Purchases of marketable securities (562)
Proceeds from sale of marketable securities 3,000,000 (0)
Net cash provided by investing activities 2,999,438
Cash flows from financing activities    
Net proceeds form note payable 1,800,000
Net proceeds from borrowings (5,818)
Net cash provided by financing activities 1,794,182
Net increase in cash 633,256 289,000
Cash at beginning of period 555,967 148,284
Cash at end of period 1,189,223 437,284
Supplemental cash flow information    
Income Taxes